Lunar Ventures — 2026 Investments
3 investments dated 2026 · listed companies and verified rows first · show all
Axiom Therapeutics runs a drug discovery platform for covalent inhibitors, applying machine learning to speed up physics-based simulations.
BiotechLondon, GB
Ryan Geiser(CEO)inChris Haggard(CTO)inSofia Dahoune(Director)Ryan Geiser, PhD(Founder)in
Co-investorsCreative Destruction Lab (CDL)Entrepreneur FirstGaingelsPlug and Play VenturesSamos InvestmentsTranspose Platform Management+2 more
data.world offers a data marketplace that presents an organization's most-used data products in an e-commerce-style shopping experience, with domain-based organization and curated views.
AI & Machine LearningData & InfrastructureEnterprise SoftwareSaaS
Co-investorsAKAR Ventures llcAlumni VenturesATPChicago VenturesLiveOak Venturesmark vc+9 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Oshen
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





__Twitter.png)




